Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy.
Boerekamps A, van den Berk GE, Lauw FN, Leyten EM, van Kasteren ME, van Eeden A, Posthouwer D, Claassen MA, Dofferhoff AS, Verhagen DWM, Bierman WF, Lettinga KD, Kroon FP, Delsing CE, Groeneveld PH, Soetekouw R, Peters EJ, Hullegie SJ, Popping S, van de Vijver DAMC, Boucher CA, Arends JE, Rijnders BJ. Boerekamps A, et al. Among authors: kroon fp. Clin Infect Dis. 2018 Apr 17;66(9):1360-1365. doi: 10.1093/cid/cix1007. Clin Infect Dis. 2018. PMID: 29186320
A randomized controlled study of accelerated versus standard hepatitis B vaccination in HIV-positive patients.
de Vries-Sluijs TE, Hansen BE, van Doornum GJ, Kauffmann RH, Leyten EM, Mudrikova T, Brinkman K, den Hollander JG, Kroon FP, Janssen HL, van der Ende ME, de Man RA. de Vries-Sluijs TE, et al. Among authors: kroon fp. J Infect Dis. 2011 Apr 1;203(7):984-91. doi: 10.1093/infdis/jiq137. Epub 2011 Jan 25. J Infect Dis. 2011. PMID: 21266513 Clinical Trial.
Effectiveness and cost-effectiveness of a nurse-delivered intervention to improve adherence to treatment for HIV: a pragmatic, multicentre, open-label, randomised clinical trial.
de Bruin M, Oberjé EJM, Viechtbauer W, Nobel HE, Hiligsmann M, van Nieuwkoop C, Veenstra J, Pijnappel FJ, Kroon FP, van Zonneveld L, Groeneveld PHP, van Broekhuizen M, Evers SMAA, Prins JM. de Bruin M, et al. Among authors: kroon fp. Lancet Infect Dis. 2017 Jun;17(6):595-604. doi: 10.1016/S1473-3099(16)30534-5. Epub 2017 Mar 3. Lancet Infect Dis. 2017. PMID: 28262598 Clinical Trial.
Cost-effectiveness and Cost-utility of the Adherence Improving Self-management Strategy in Human Immunodeficiency Virus Care: A Trial-based Economic Evaluation.
Wijnen BFM, Oberjé EJM, Evers SMAA, Prins JM, Nobel HE, van Nieuwkoop C, Veenstra J, Pijnappel FJ, Kroon FP, van Zonneveld L, van Hulzen AGW, van Broekhuizen M, de Bruin M. Wijnen BFM, et al. Among authors: kroon fp. Clin Infect Dis. 2019 Feb 1;68(4):658-667. doi: 10.1093/cid/ciy553. Clin Infect Dis. 2019. PMID: 30239629 Clinical Trial.
Hepatitis B surface antigen declines and clearance during long-term tenofovir therapy in patients coinfected with HBV and HIV.
Zoutendijk R, Zaaijer HL, de Vries-Sluijs TE, Reijnders JG, Mulder JW, Kroon FP, Richter C, van der Eijk AA, Sonneveld MJ, Hansen BE, de Man RA, van der Ende ME, Janssen HL. Zoutendijk R, et al. Among authors: kroon fp. J Infect Dis. 2012 Sep 15;206(6):974-80. doi: 10.1093/infdis/jis439. Epub 2012 Jul 10. J Infect Dis. 2012. PMID: 22782950
[Prevention of severe infections in patients with hyposplenism or asplenia].
Lammers AJ, van der Maas N, Peters EJ, Meerveld-Eggink A, Sanders EA, Kroon FP; De Werkgroep voor Infectiepreventie bij Hyposplenia en Asplenia. Lammers AJ, et al. Among authors: kroon fp. Ned Tijdschr Geneeskd. 2012;156(44):A4857. Ned Tijdschr Geneeskd. 2012. PMID: 23114171 Dutch.
Effects of active treatment discontinuation in patients with a CD4+ T-cell nadir greater than 350 cells/mm3: 48-week Treatment Interruption in Early Starters Netherlands Study (TRIESTAN).
Pogány K, van Valkengoed IG, Prins JM, Nieuwkerk PT, van der Ende I, Kauffmann RH, Kroon FP, Verbon A, Nievaard MF, Lange JM, Brinkman K. Pogány K, et al. Among authors: kroon fp. J Acquir Immune Defic Syndr. 2007 Apr 1;44(4):395-400. doi: 10.1097/QAI.0b013e31802f83bc. J Acquir Immune Defic Syndr. 2007. PMID: 17195761 Clinical Trial.
Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism.
Burger D, van der Heiden I, la Porte C, van der Ende M, Groeneveld P, Richter C, Koopmans P, Kroon F, Sprenger H, Lindemans J, Schenk P, van Schaik R. Burger D, et al. Br J Clin Pharmacol. 2006 Feb;61(2):148-54. doi: 10.1111/j.1365-2125.2005.02536.x. Br J Clin Pharmacol. 2006. PMID: 16433869 Free PMC article.
204 results